Novak-Lauš Katia, Knežević Lana, Marić Goran, Zorić Geber Mia, Vatavuk Zoran
Department of Ophthalmology, Sestre milosrdnice University Hospital Centre, Zagreb, Croatia.
Acta Clin Croat. 2019 Dec;58(4):767-770. doi: 10.20471/acc.2019.58.04.25.
The XEN gel stent is one of the available minimally invasive glaucoma surgery devices, a new generation implant, which is designed to reduce intraocular pressure in patients with primary open angle glaucoma if past medical treatments have failed. This report presents a case of subconjunctival fragmentation of the XEN gel stent after a three-month follow-up of successful XEN gel implantation. A 70-year-old male patient was treated for primary open angle glaucoma. He underwent successful phacoemulsification and intraocular lens implantation two years before. Due to medical therapy failure in controlling glaucoma, XEN gel stent implantation was suggested to the patient. The implant was successfully placed in both eyes, and extended bleb and drainage aqueous humor from the anterior chamber to the subconjunctival space was obtained. Three months after the surgery, at a regular follow-up visit, three fragments of the subconjunctival part of the XEN gel implant were found in his left eye. Neither serious complications nor intraocular pressure increase were detected. A new potential complication of the XEN gel implant is described.
XEN凝胶支架是现有的微创青光眼手术设备之一,是一种新一代植入物,旨在在过去的药物治疗失败时降低原发性开角型青光眼患者的眼压。本报告介绍了一例XEN凝胶支架植入成功后三个月随访出现结膜下支架碎裂的病例。一名70岁男性患者因原发性开角型青光眼接受治疗。他两年前成功接受了白内障超声乳化吸除术和人工晶状体植入术。由于药物治疗无法控制青光眼,建议该患者植入XEN凝胶支架。该植入物成功植入双眼,获得了从眼内延伸至结膜下间隙的滤过泡并引流房水。手术后三个月,在定期随访中,在其左眼发现了XEN凝胶植入物结膜下部分的三个碎片。未检测到严重并发症或眼压升高。本文描述了XEN凝胶植入物一种新的潜在并发症。